Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2018

Open Access 01.12.2018 | Case report

Yellow nail syndrome with chylothorax after coronary artery bypass grafting

verfasst von: Sarah Waliany, Julia Chandler, David Hovsepian, Jack Boyd, Natalie Lui

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2018

Abstract

Background

Yellow nail syndrome is a rare condition considered secondary to functional anomalies of lymphatic drainage. Yellow nail syndrome is diagnosed through the triad of intrathoracic findings (30% being pleural effusions), nail discoloration, and lymphedema, with any two features sufficient for diagnosis. We report the second case of post-operative yellow nail syndrome.

Case presentation

After coronary artery bypass grafting, our patient presented with chylothorax on post-operative day 13 and yellow toenail discoloration on post-operative day 28, diagnosing yellow nail syndrome. Initial conservative management with pigtail catheter drainage and low-fat diet with medium-chain triglycerides reduced chylous drainage from 350 mL/day on post-operative day 14 to < 100 mL/day on post-operative day 17. However, by post-operative day 18, drainage returned to 350 mL/day that persisted despite attempts to readjust the catheter position, replacement of catheter with chest tube, and transition to total parenteral nutrition and octreotide while nil per os. Lymphangiogram on post-operative day 32 did not identify the thoracic duct or cisterna chyli, precluding embolization. Talc and doxycycline pleurodeses performed on post-operative days 33 and 38, respectively, resolved his chylothorax and nail discoloration.

Conclusions

Both yellow nail syndrome and chylothorax as a complication of coronary artery bypass grafting are rare entities. The proposed mechanism of post-operative chylothorax is iatrogenic injury to thoracic duct or collateral lymphatic vessels. Diagnosing yellow nail syndrome in patients with post-operative chylothorax (through co-existing yellow nail discoloration and/or lymphedema) may suggest predisposition to impaired lymphatic drainage, portending a difficult recovery and potentially indicating need for surgical management.
Abkürzungen
CABG
Coronary artery bypass grafting
ITA
Internal thoracic artery
POD
Post-operative day
TPN
Total parenteral nutrition
YNS
Yellow nail syndrome

Background

Yellow nail syndrome (YNS) is a rare condition of unclear etiology considered secondary to functional anomalies of lymphatic drainage. YNS is characterized by the triad of nail changes, intrathoracic findings (30% being pleural effusions), and lymphedema, with only two of the triad elements required for diagnosis (typically nail discoloration with one of the other findings) [1]. Most cases of YNS have been associated with malignancies, especially lymphoma; autoimmune disorders; immunodeficiencies; endocrine diseases; and others. We report the second case, to our knowledge, of YNS associated with surgery; the first reported case of post-operative YNS was also diagnosed after coronary artery bypass grafting (CABG). We also review the literature on the 41 prior reported cases of chylothorax diagnosed after CABG.

Case presentation

A 62-year-old man with coronary artery disease underwent four-vessel CABG including left internal thoracic artery (ITA) to left anterior descending artery. The patient was discharged on postoperative day (POD) 6 after an uneventful postoperative course with low chest tube output and trace pleural effusions.
On POD 13, the patient was readmitted after four days of moderate chest pain and exertional dyspnea. Diminished respiratory sounds were noted over the full left lung field. Chest radiograph confirmed a large left pleural effusion (Fig. 1). A left pigtail catheter drained 2.3 l of milky fluid with a triglyceride level of 1604 mg/dL, diagnosing chylothorax.
Conservative management was attempted with continued catheter drainage and initiation of a low-fat diet with medium-chain triglycerides on POD 14. Drainage gradually decreased over the next three days to < 100 ml/day, but by POD 18, drainage increased to 350 mL/day that continued for two days despite attempts to readjust the catheter position. On POD 20, the pigtail catheter was replaced with a chest tube, and the patient was transitioned to total parenteral nutrition (TPN) and octreotide while nil per os, but chest tube drainage persisted at 200–360 ml/day. On POD 28, the patient noted new, bilateral yellow toenail discoloration (Fig. 2). The yellow nail discoloration was not associated with any disfiguring features such as nail thickening or separation from nail bed. No lymphedema was found. Presence of yellow nails and chylothorax resulted in diagnosis of YNS.
Lymphangiogram on POD 32 noted well-opacified pelvic lymphatic channels, but cisterna chyli and thoracic duct were not identified (Fig. 3), precluding embolization. Tiny droplets of lipiodol were present in the left pleural space, but the leak location could not be identified.
On POD 33, thoracoscopic left pleurodesis was performed using aerosolized talc (4 g). Prior to talc administration, half-and-half (300 mL) was administered via nasogastric tube, but no chyle leak was found on thoracoscopic examination after two hours. Since lymphangiogram did not identify a thoracic duct, thoracic duct ligation was not attempted. Five days after pleurodesis, since chest tube output remained high (> 200–300 ml/day), doxycycline pleurodesis was performed via existing chest tube. Output subsequently decreased, allowing transition to low-fat diet seven days later and discharge home two days after that.
At 2- and 8-week follow-ups, chest radiograph showed trace pleural effusion with no recurrence of chylothorax. Although still on a low-fat diet at both visits, the patient was gradually increasing fat intake. Yellow toenail discoloration had resolved by the 8-week follow-up.

Discussion

YNS is diagnosed clinically through the triad of characteristic nail changes, intrathoracic findings (30% being pleural effusions), and lymphedema. Presence of any two features (typically nail discoloration with another finding) is sufficient for diagnosis [1], with the full triad observed in one-third of cases [2]. About 30% of YNS-associated pleural effusions are chylothoraces [3].
Since the first report in 1964 [4], fewer than 400 cases of YNS have been described in the literature. The etiology remains unknown, with prior associations including malignancies (especially lymphoma), immunodeficiency disorders, tuberculosis, diabetes mellitus, thyroid dysfunction, Guillan-Barré syndrome, and others. This is the second report of YNS associated with surgery; the first reported case was also diagnosed after CABG [5].
Although debated, the pathophysiology of YNS is attributed to functional lymphatic defects, with lymphangiogram and lymphoscintigraphy findings of hypoplastic lymphatic vessels [4] and reduced lymphatic drainage in extremities [6]. Nail discoloration results from lipofuscin pigment from oxidation of lipid precursors in soft tissue lymph collections. The conditions associated with YNS are considered to be second insults causing functionally anomalous lymphatics to present clinically through intrathoracic findings, nail changes, and/or edema.
Our report indicates that traumatic disruption of lymphatic vessels may be another trigger causing functionally anomalous lymphatics to manifest clinically as YNS. Intra-operative damage to thoracic duct or other lymphatic tributaries may have overwhelmed the lymphatic network, causing accumulation of chyle in the pleural space as chylothorax and in lower extremity soft tissues manifesting as yellow nails. Although our patient did not have visible lymphedema, a previous study showed that patients with YNS without edema still had significantly reduced lymphatic drainage in lower extremities on lymphoscintigraphy compared with control patients [6]; this suggests that our patient’s lymph collection may have been sufficient to cause lipofuscin accumulation but not edema.
Post-CABG chylothorax is also rare, with 41 other reported cases (Table 1). The proposed mechanism is iatrogenic injury to the thoracic duct or collateral lymphatic vessels. A strong association exists with left ITA harvesting (involving 81.0% of the 42 cases including ours) due to close proximity between the left ITA origin and thoracic duct. Another risk factor is use of electrocautery during harvesting; due to low protein in lymph (compared with blood), electrocautery of lymphatics increases risk of leakage rather than achieving lymphostasis [7].
Table 1
Reported cases of chylothorax diagnosed after coronary artery bypass grafting
Reference
Year
Sex
Age
Procedure
L ITA
R ITA
Chylothorax site
POD
Outcome with conservative tx
Octreotide?
Surgical tx
Weber [10]
1981
M
55
CABG
Yes
No
L & M
2
Resolved after 12d
No
None
Zakhour [11]
1981
M
73
CABG
Yes
No
L
90
Resolved after 21d
No
None
Zakhour [11]
1981
M
59
CABG
No
No
L & M
2
Resolved after 5d
No
None
Kshettry [12]
1981
M
51
CABG
No
No
L
30
Resolved after 4d
No
None
Teba [13]
1985
F
51
CABG/MVR
No
No
L
7
Resolved after 17d
No
None
Di Lello [14]
1987
M
53
CABG
Yes
No
L
9
Failed after 31d
No
L thoracotomy-fibrin glue
Czarnecki [15]
1988
F
61
CABG
Yes
Yes
R
42
Failed after 10d
No
R thoracotomy-ligation at diaphragm
Chaiyaroji [16]
1991
F
69
CABG
Yes
No
L
6
Failed after 18d
No
L thoracotomy-ligation at injury
Inderbitzi [17]
1992
M
69
CABG/Redo
UK
UK
L
2
Failed after 21d
No
Left VATS - fibrin glue
Bogers [18]
1993
M
41
CABG
Yes
No
L
1
Failed after 35d
No
L thoracotomy-ligation at injury
Janssen [19]
1994
M
58
CABG
Yes
No
L
35
Failed after 14d
No
L VATS-ligation at injury
Davies [20]
1994
M
48
CABG
Yes
No
L
21
Resolved after 28d
No
None
Wood [21]
1994
M
69
CABG
Yes
No
L
3
Failed after 7d
No
L VATS-ligation at injury
Smith [22]
1994
M
60
CABG
Yes
No
L
14
Resolved after 15d
No
None
Smith [22]
1994
M
47
CABG
Yes
No
L
7
Resolved after 14d
No
None
Zaidenstein [23]
1996
F
70
CABG
Yes
No
L
42
Resolved after 16d
No
None
Felz [24]
1997
F
50
CABG
Yes
No
L
56
Resolved after 59d
No
None
Mohanty [25]
1998
M
56
CABG
Yes
No
L
8
Resolved after 22d
No
Attempted wiring of dehisced sternum on day 9 after diagnosis
Sharpe [26]
1999
F
63
CABG
No
No
L & M
11
Resolved after 14d
No
None
Perez [27]
1999
M
68
CABG/AVR
UK
UK
L
10
Resolved after 10d
No
None
Pego-Fernandez [28]
1999
M
38
CABG
Yes
No
L
90
Resolved after 17d
No
None
Kelly [29]
2000
M
77
CABG
Yes
No
L
18
Resolved after 14d
Yes
None
Fahimi [30]
2001
M
49
CABG
Yes
No
L
UK
Failed after 14d
No
L VATS-fibrin glue
Fahimi [30]
2001
M
51
CABG
Yes
No
L
UK
Resolved after 14d
No
None
Brancaccio [31]
2001
M
64
CABG
Yes
No
L
6
Resolved after 11d
No
None
Abid [32]
2003
M
58
CABG
Yes
No
L
3
Failed after 8d
No
Talc slurry pleurodesis
Riquet [33]
2004
F
59
CABG
Yes
No
L
UK
Failed after 78d
No
L thoracotomy-ligation at injury
Gabbieri [34]
2004
F
67
CABG
Yes
No
L
10
Resolved after 28d
Yes
None
Kilic [35]
2005
F
66
CABG
Yes
No
L
12
Resolved after 10d
Yes
None
Falode [36]
2005
F
68
CABG/ASD
Yes
No
L
3
Failed after 60d
No
L VATS-dry talc pleurodesis
Barbetakis [37]
2005
M
78
CABG
Yes
No
L
27
Resolved after 13d
Yes
None
Halldorsson [38]
2006
F
47
CABG
No
No
R
10
Resolved after 10d
No
None
Choong [39]
2006
M
63
CABG
Yes
No
L
2
Failed after 35d
No
R thoracotomy-ligation at diaphragm
Narayan [40]
2007
F
65
CABG/MVR
Yes
No
UK
1
Failed after 3d
Yes
Median sternotomy-ligation at injury
Paul [41]
2009
M
65
CABG
UK
UK
L
UK
Failed after 14d
UK
R thoracotomy-thoracic duct ligation
Karimi [42]
2010
M
53
CABG
Yes
No
L
2
Resolved after 27d
No
None
Deguchi [43]
2013
F
78
CABG
Yes
Yes
R
3
Failed after 10d
Yes
Median sternotomy-ligation at injury
Altun [44]
2015
M
60
CABG
Yes
No
UK
2
Resolved after 13d
Yes
None
Altun [44]
2015
M
46
CABG
Yes
No
UK
3
Resolved after 14d
Yes
None
Owais [45]
2015
F
76
CABG
Yes
No
L
15
Resolved after 7d
Yes
None
Sabzi [7]
2017
M
43
CABG
Yes
No
L
0
Resolved after 10d
No
None
Abbreviations: M = Male, F = Female, ITA = internal thoracic artery, L = Left, R = Right, M = Mediastinum, UK = Unknown, POD = “post-operative day” when chylothorax was diagnosed, d = days, tx = treatment, CABG = coronary artery bypass graft, MVR = mitral valve replacement, AVR = Aortic Valve Replacement, ASD = Atrial Septal Defect repair, VATS = video-assisted thoracoscopic surgery
An updated adaptation from Halldorsson [38] and Deguchi [43]
Management of post-operative chylothorax starts with conservative measures, including chest tube for effusion drainage. Efforts to decrease chyle production include a trial of low-fat diet with medium-chain triglycerides (absorbed directly into portal system) with transition to TPN and somatostatin or octreotide if output remains high [8]. Conservative management has failed if output exceeds 1 L/day for five days; drainage persists for more than fourteen days; or nutritional status declines. Of the 41 prior cases with post-CABG chylothorax, 26 (63.4%) succeeded with conservative management with all but one resolving in less than 30 days; the other 15 (36.6%) underwent surgery after a median (range) of 14 (3–78) days. In our patient’s case, conservative measures with pigtail catheter drainage and low-fat diet were initially successful at reducing chylous drainage during the first four days of management; however, drainage increased by the fifth day of management likely due to a malfunction of the catheter. Additional conservative measures (chest tube drainage, total parenteral nutrition, and octreotide while nil per os) were continued for an additional 14 days before attempting lymphangiogram; of the 26 reported post-CABG chylothoraces that resolved without surgical intervention, 14 (53.8%) required 14–28 days of conservative management before resolving (see Table 1).
When conservative management fails, thoracoscopic or open thoracic duct ligation with chemical pleurodesis can be done [9]. In chylothorax management at our medical center, it is institutional practice to start with lymphangiogram and minimally-invasive thoracic duct embolization before attempting surgical thoracic duct ligation as our Department of Interventional Radiology has a history of success with the less invasive procedure; in the event that duct embolization fails, lymphangiogram may guide future surgical measures. In our patient’s case, the lymphangiogram guided the surgical team to attempt pleurodesis without thoracic duct ligation since the thoracic duct was not identified.
Although this is the second report, to our knowledge, of post-CABG yellow nail syndrome, it is possible that the other YNS features (yellow nails and lymphedema) have previously been missed in patients with post-CABG chylothorax since the findings are subtle. Other cases may have been misdiagnosed as fungal infections. In our patient’s case, the close temporal association between the development of chylothorax and appearance of yellow nail discoloration and the temporal proximity of their resolution were more consistent with YNS. Furthermore, the appearance of his nails was less consistent with onychomycosis. Other than yellow discoloration, his nails had no disfiguring features such as thickening, chipping, or separation from the nail bed; his nails also demonstrated a uniform yellow discoloration without black debris. Overall, the appearance of his nails was not consistent with any of the major subtypes of onychomycosis (such as distal and lateral subungual; proximal subungual; endonyx subungual; superficial; or total dystrophic onychomycosis) [10].
Although diagnosing YNS does not alter management, we propose that concurrence of chylothorax with yellow nails and/or lymphedema may suggest predisposition to impaired lymphatic drainage and serve as a marker of degree of lymphatic leakage, portending a difficult recovery course and potentially indicating need for surgical intervention. As our patient’s recovery was challenging (failing conservative treatment and requiring both talc and doxycycline pleurodeses), it is possible that he had a lymphatic aberrancy predisposing to YNS, with intraoperative thoracic duct injury serving as the second insult that caused YNS to manifest clinically.

Conclusions

Chylothorax as a complication of coronary artery bypass grafting is rare, with the most likely mechanism being iatrogenic injury to the thoracic duct or collateral lymphatic vessels. During management of post-operative chylothorax, diagnosis of yellow nail syndrome (through concurrent presence of yellow nail discoloration and/or lymphedema) may suggest a predisposition to impaired lymphatic drainage, potentially indicating the need for surgical management.
Not applicable.
We have obtained written consent from the patient to publish the medical data in this case report.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Hiller E, Rosenow EC, Olsen AM. Pulmonary manifestations of the yellow nail syndrome. Chest. 1972;61(5):452–8.CrossRefPubMed Hiller E, Rosenow EC, Olsen AM. Pulmonary manifestations of the yellow nail syndrome. Chest. 1972;61(5):452–8.CrossRefPubMed
3.
Zurück zum Zitat Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest. 2008;134(2):375–81.CrossRefPubMed Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest. 2008;134(2):375–81.CrossRefPubMed
4.
5.
Zurück zum Zitat Banta DP, Dandamudi N, Parekh HJ, Anholm JD. Yellow nail syndrome following thoracic surgery: a new association? J Postgr Med. 2009;55(4):270–1.CrossRef Banta DP, Dandamudi N, Parekh HJ, Anholm JD. Yellow nail syndrome following thoracic surgery: a new association? J Postgr Med. 2009;55(4):270–1.CrossRef
6.
Zurück zum Zitat Bull RH, Fenton DA, Mortimer PS. Lymphatic function in the yellow nail syndrome. Br J Dermatol. 1996;134(2):307–12.CrossRefPubMed Bull RH, Fenton DA, Mortimer PS. Lymphatic function in the yellow nail syndrome. Br J Dermatol. 1996;134(2):307–12.CrossRefPubMed
7.
Zurück zum Zitat Sabzi F, Faraji R. Early Chylothorax after coronary artery bypass grafting. Zahedan J Res Med Sci 2017;In press:e9067. Sabzi F, Faraji R. Early Chylothorax after coronary artery bypass grafting. Zahedan J Res Med Sci 2017;In press:e9067.
8.
Zurück zum Zitat Owais T, Back D, Girdauskas E, Kuntze T. Postoperative Chylothorax: is octreotide a valid therapy? J Case Reports Stud. 2015;3(3). Owais T, Back D, Girdauskas E, Kuntze T. Postoperative Chylothorax: is octreotide a valid therapy? J Case Reports Stud. 2015;3(3).
9.
Zurück zum Zitat McGrath EE, Blades Z, Anderson PB. Chylothorax: Aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1–8.CrossRefPubMed McGrath EE, Blades Z, Anderson PB. Chylothorax: Aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1–8.CrossRefPubMed
10.
Zurück zum Zitat Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762–70.PubMed Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762–70.PubMed
11.
Zurück zum Zitat Weber DO, Del Mastro P, Yarnoz MD. Chylothorax after myocardial revascularization with internal mammary graft. Ann Thorac Surg. 1981;32(5):499–502.CrossRefPubMed Weber DO, Del Mastro P, Yarnoz MD. Chylothorax after myocardial revascularization with internal mammary graft. Ann Thorac Surg. 1981;32(5):499–502.CrossRefPubMed
12.
Zurück zum Zitat Zakhour B, Drucker M, Franco A. Chylothorax as a complication of aortocoronary bypass. Two case reports and a review of the literature. Scand J Thorac Cardiovasc Surg. 1988;22(1):93–5.CrossRefPubMed Zakhour B, Drucker M, Franco A. Chylothorax as a complication of aortocoronary bypass. Two case reports and a review of the literature. Scand J Thorac Cardiovasc Surg. 1988;22(1):93–5.CrossRefPubMed
14.
Zurück zum Zitat Teba L, Dedhia HV, Bowen R, Alexander JC. Chylothorax review. Crit Care Med. 1985;13(1):49–52.CrossRefPubMed Teba L, Dedhia HV, Bowen R, Alexander JC. Chylothorax review. Crit Care Med. 1985;13(1):49–52.CrossRefPubMed
15.
Zurück zum Zitat Di Lello F, Werner PH, Kleinman LH, Mullen DC, Flemma RJ. Life-threatening Chylothorax after left internal mammary artery dissection: therapeutic considerations. Ann Thorac Surg. 1987;44(6):660–1.CrossRefPubMed Di Lello F, Werner PH, Kleinman LH, Mullen DC, Flemma RJ. Life-threatening Chylothorax after left internal mammary artery dissection: therapeutic considerations. Ann Thorac Surg. 1987;44(6):660–1.CrossRefPubMed
16.
Zurück zum Zitat Czarnecki DJ, Kehoe ME, Tector AJ. Lymphangiographic evaluation of chylothorax after myocardial revascularization. Am J Roentgenol. 1988;151(5):1054–5.CrossRef Czarnecki DJ, Kehoe ME, Tector AJ. Lymphangiographic evaluation of chylothorax after myocardial revascularization. Am J Roentgenol. 1988;151(5):1054–5.CrossRef
17.
Zurück zum Zitat Chaiyaroj S, Mullerworth MH, Tatoulis J. Surgery in the management of chylothorax after coronary artery bypass with left internal mammary artery. J Thorac Cardiovasc Surg. 1993;106(4):754–6.PubMed Chaiyaroj S, Mullerworth MH, Tatoulis J. Surgery in the management of chylothorax after coronary artery bypass with left internal mammary artery. J Thorac Cardiovasc Surg. 1993;106(4):754–6.PubMed
18.
Zurück zum Zitat Inderbitzi RG, Krebs T, Stirneman T, Ulrich A. Treatment of postoperative chylothorax by fibrin glue application under thoracoscopic view with use of local anesthesia. J Thorac Cardiovasc Surg. 1992;104(1):209–10.PubMed Inderbitzi RG, Krebs T, Stirneman T, Ulrich A. Treatment of postoperative chylothorax by fibrin glue application under thoracoscopic view with use of local anesthesia. J Thorac Cardiovasc Surg. 1992;104(1):209–10.PubMed
19.
Zurück zum Zitat Bogers AJ, Pardijs WH, Van Herwerden LA, Bos E. Chylothorax as a complication of harvesting the left internal thoracic artery in coronary artery bypass surgery. Eur J Cardio-thoracic Surg. 1993;7(10) Bogers AJ, Pardijs WH, Van Herwerden LA, Bos E. Chylothorax as a complication of harvesting the left internal thoracic artery in coronary artery bypass surgery. Eur J Cardio-thoracic Surg. 1993;7(10)
20.
Zurück zum Zitat Janssen JP, Joosten HJM, Postmus PE. Thoracoscopic treatment of postoperative chylothorax after coronary bypass surgery. Thorax. 1994;49(12):1273.CrossRefPubMedPubMedCentral Janssen JP, Joosten HJM, Postmus PE. Thoracoscopic treatment of postoperative chylothorax after coronary bypass surgery. Thorax. 1994;49(12):1273.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Davies MJ, Spyt TJ. Chylothorax and wound lymphocele formation as a complication of myocardial revascularization with the internal thoracic artery. J Thorac Cardiovasc Surg. 1994;108(6):1155–6.PubMed Davies MJ, Spyt TJ. Chylothorax and wound lymphocele formation as a complication of myocardial revascularization with the internal thoracic artery. J Thorac Cardiovasc Surg. 1994;108(6):1155–6.PubMed
22.
Zurück zum Zitat Wood MK, Ullyot DJ. Chylothorax. J Thorac Cardiovasc Surg. 1994;108(6):1156.PubMed Wood MK, Ullyot DJ. Chylothorax. J Thorac Cardiovasc Surg. 1994;108(6):1156.PubMed
23.
Zurück zum Zitat Smith JA, Goldstein J, Oyer PE. Chylothorax complicating coronary artery by-pass grafting. J Cardiovasc Surg. 1994;35(4):307–9. Smith JA, Goldstein J, Oyer PE. Chylothorax complicating coronary artery by-pass grafting. J Cardiovasc Surg. 1994;35(4):307–9.
24.
Zurück zum Zitat Zaidenstein R, Cohen N, Dish V, Alon I, Golik A, Modai D. Chylothorax following median sternotomy. Clin Cardiol. 1996;19(11):910–2.CrossRefPubMed Zaidenstein R, Cohen N, Dish V, Alon I, Golik A, Modai D. Chylothorax following median sternotomy. Clin Cardiol. 1996;19(11):910–2.CrossRefPubMed
25.
Zurück zum Zitat Felz MW, Neely J. Beware the left-sided effusion. J Fam Pract. 1997;45(6):519–22.PubMed Felz MW, Neely J. Beware the left-sided effusion. J Fam Pract. 1997;45(6):519–22.PubMed
26.
Zurück zum Zitat Mohanty B, Craddock D, Stubberfield J. Chylothorax: an unusual complication following coronary artery bypass grafting using the left internal mammary artery. Asia Pacific Hear J. 1998;7(3):220–2.CrossRef Mohanty B, Craddock D, Stubberfield J. Chylothorax: an unusual complication following coronary artery bypass grafting using the left internal mammary artery. Asia Pacific Hear J. 1998;7(3):220–2.CrossRef
27.
Zurück zum Zitat Sharpe DA, Pullen MD, McGoldrick JP. A minimally invasive approach to chylopericardium after coronary artery surgery. Ann Thorac Surg. 1999;68(3):1062–3.CrossRefPubMed Sharpe DA, Pullen MD, McGoldrick JP. A minimally invasive approach to chylopericardium after coronary artery surgery. Ann Thorac Surg. 1999;68(3):1062–3.CrossRefPubMed
28.
Zurück zum Zitat Pérez J, Casal J, Rodríguez W. Always remember chylothorax. South Med J. 1999;92(8):833–5.CrossRefPubMed Pérez J, Casal J, Rodríguez W. Always remember chylothorax. South Med J. 1999;92(8):833–5.CrossRefPubMed
29.
Zurück zum Zitat Pêgo-Fernandes PM, Ebaid GX, Nouer GH, Munhoz RT, Jatene FB, Jatene AD. Chylothorax after myocardial revascularization with the left internal thoracic artery. Arq Bras Cardiol. 1999;73(4):383–90.CrossRefPubMed Pêgo-Fernandes PM, Ebaid GX, Nouer GH, Munhoz RT, Jatene FB, Jatene AD. Chylothorax after myocardial revascularization with the left internal thoracic artery. Arq Bras Cardiol. 1999;73(4):383–90.CrossRefPubMed
30.
Zurück zum Zitat Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg. 2000;69(6):1944–5.CrossRefPubMed Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg. 2000;69(6):1944–5.CrossRefPubMed
31.
Zurück zum Zitat Fahimi H, Casselman FP, Mariani MA, et al. Current management of postoperative chylothorax. Ann Thorac Surg. 2001;71(2):448–50.CrossRefPubMed Fahimi H, Casselman FP, Mariani MA, et al. Current management of postoperative chylothorax. Ann Thorac Surg. 2001;71(2):448–50.CrossRefPubMed
32.
Zurück zum Zitat Brancaccio G, Prifti E, Cricco AM, Totaro M, Antonazzo A, Miraldi F. Chylothorax: a complication after internal thoracic artery harvesting. Ital Heart J. 2001;2(7):559–62.PubMed Brancaccio G, Prifti E, Cricco AM, Totaro M, Antonazzo A, Miraldi F. Chylothorax: a complication after internal thoracic artery harvesting. Ital Heart J. 2001;2(7):559–62.PubMed
33.
Zurück zum Zitat Abid Q, Millner RW. Chylothorax following coronary bypass grafting: treatment by talc pleurodesis. Asian Cardiovasc Thorac Ann. 2003;11(4):355–6.CrossRefPubMed Abid Q, Millner RW. Chylothorax following coronary bypass grafting: treatment by talc pleurodesis. Asian Cardiovasc Thorac Ann. 2003;11(4):355–6.CrossRefPubMed
34.
Zurück zum Zitat Riquet M, Assouad J, D’Attellis N, Gandjbakhch I. Chylothorax and re-expansion pulmonary edema following myocardial re-vascularization: role of lymph vessel insufficiency. Interact Cardiovasc Thorac Surg. 2004;3(3):423–5.CrossRefPubMed Riquet M, Assouad J, D’Attellis N, Gandjbakhch I. Chylothorax and re-expansion pulmonary edema following myocardial re-vascularization: role of lymph vessel insufficiency. Interact Cardiovasc Thorac Surg. 2004;3(3):423–5.CrossRefPubMed
35.
Zurück zum Zitat Gabbieri D, Bavutti L, Zaca F, Turinetto B, Ghidoni I. Conservative treatment of postoperative chylothorax with octreotide. Ital Heart J. 2004;5(6):479–82.PubMed Gabbieri D, Bavutti L, Zaca F, Turinetto B, Ghidoni I. Conservative treatment of postoperative chylothorax with octreotide. Ital Heart J. 2004;5(6):479–82.PubMed
36.
Zurück zum Zitat Kilic D, Sahin E, Gulcan O, Bolat B, Turkoz R, Hatipoglu A. Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J. 2005;32(3):437–9.PubMedPubMedCentral Kilic D, Sahin E, Gulcan O, Bolat B, Turkoz R, Hatipoglu A. Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J. 2005;32(3):437–9.PubMedPubMedCentral
38.
Zurück zum Zitat Barbetakis N, Xenikakis T, Efstathiou A, Fessatidis I. Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature. Hell J Cardiol. 2006;47(2):118–22. Barbetakis N, Xenikakis T, Efstathiou A, Fessatidis I. Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature. Hell J Cardiol. 2006;47(2):118–22.
39.
Zurück zum Zitat Halldorsson A. Chylothorax after coronary artery bypass grafting. Int Surg. 94(2):119–29. Halldorsson A. Chylothorax after coronary artery bypass grafting. Int Surg. 94(2):119–29.
40.
Zurück zum Zitat Choong CK, Martinez C, Barner HB. Chylothorax after internal thoracic artery harvest. Ann Thorac Surg. 2006;81(4):1507–9.CrossRefPubMed Choong CK, Martinez C, Barner HB. Chylothorax after internal thoracic artery harvest. Ann Thorac Surg. 2006;81(4):1507–9.CrossRefPubMed
41.
Zurück zum Zitat Narayan P, Rahaman N, Molnar TF, Caputo M. Chylothorax following cardiac surgery caused by unusual lymphatic anatomy. Asian Cardiovasc Thorac Ann. 2007;15(5):e58–9.CrossRefPubMed Narayan P, Rahaman N, Molnar TF, Caputo M. Chylothorax following cardiac surgery caused by unusual lymphatic anatomy. Asian Cardiovasc Thorac Ann. 2007;15(5):e58–9.CrossRefPubMed
42.
Zurück zum Zitat Paul S, Altorkl NK, Port JL, Stiles BM, Lee PC. Surgical management of chylothorax. Thorac Cardiovasc Surg. 2009;57(4):226–8.CrossRefPubMed Paul S, Altorkl NK, Port JL, Stiles BM, Lee PC. Surgical management of chylothorax. Thorac Cardiovasc Surg. 2009;57(4):226–8.CrossRefPubMed
43.
Zurück zum Zitat Karimi A, Salehiomran A, Yazdanifard P. Chylothorax after coronary artery bypass and internal mammary artery harvesting: a case report. East Mediterr Heal J. 2010;16(10):1103–4.CrossRef Karimi A, Salehiomran A, Yazdanifard P. Chylothorax after coronary artery bypass and internal mammary artery harvesting: a case report. East Mediterr Heal J. 2010;16(10):1103–4.CrossRef
44.
Zurück zum Zitat Deguchi K, Yamauchi T, Maeda S, Takeuchi M, Kin K, Takano H. Chylothorax after coronary artery bypass grafting using the right internal thoracic artery. Gen Thorac Cardiovasc Surg. 2015;63(7):416–21.CrossRefPubMed Deguchi K, Yamauchi T, Maeda S, Takeuchi M, Kin K, Takano H. Chylothorax after coronary artery bypass grafting using the right internal thoracic artery. Gen Thorac Cardiovasc Surg. 2015;63(7):416–21.CrossRefPubMed
45.
Zurück zum Zitat Altun G, Pulathan Z, Kutanis D, Hemsinli D, Erturk E, Civelek A. Conservative Management of Chylothorax after coronary artery bypass grafting. Texas Hear Inst J. 2015;42(2):148–51.CrossRef Altun G, Pulathan Z, Kutanis D, Hemsinli D, Erturk E, Civelek A. Conservative Management of Chylothorax after coronary artery bypass grafting. Texas Hear Inst J. 2015;42(2):148–51.CrossRef
Metadaten
Titel
Yellow nail syndrome with chylothorax after coronary artery bypass grafting
verfasst von
Sarah Waliany
Julia Chandler
David Hovsepian
Jack Boyd
Natalie Lui
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2018
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-018-0784-8

Weitere Artikel der Ausgabe 1/2018

Journal of Cardiothoracic Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.